Gladstone in the News

The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.

Prevention drug still suggested to be taken daily, despite findings
September 19, 2012

Scientists led by a team at the Gladstone Institutes are getting closer to understanding how much antiretroviral medication people need to take to protect themselves from being infected with HIV.

New DNA Map May Help Cure Congenital Heart Defects
September 19, 2012

Reasearchers from Gladstone Institutes in California have created a blueprint map of how the heart developes in time.

DNA Blueprint Maps How A Heart Becomes A Heart
September 17, 2012

Using stem cell technology, next-generation DNA sequencing and computer tools, researchers at the Gladstone Institutes in California, and other academic centers, have mapped how a heart becomes a heart.

More Evidence That Truvada Can Help Prevent HIV
September 13, 2012

Truvada, the only medication approved by the U.S. Food and Drug Administration for HIV prevention, is effective in blocking the virus even if people do not adhere to their daily regimen perfectly, a new study indicates.

NIH-funded analysis estimates effective PrEP dosing
September 13, 2012

Several large clinical trials have demonstrated that a daily oral dose of one or two antiretroviral drugs used to treat HIV infection can prevent infection in an approach known as pre-exposure prophylaxis, or PrEP.

Hepatitis C drugs offer hope for cure
September 11, 2012

Scientific breakthroughs, one piled on top of another at breakneck speed over the past few years, have put medical researchers on the cusp of curing almost everyone who suffers from hepatitis C, if not wiping out the disease entirely.

Yosemite Campers Alerted To Hantavirus Infection After Two Die
August 29, 2012

Gladstone's Dr. Warner Greene weighs in on latest outbreak of hantavirus at Yosemite National Park.

Gilead battles AIDS group in drug spat
August 24, 2012

The Gladstone Institutes is conducting two other trials of Truvada as PrEP. One of those studies is looking at who takes the pill and when it is taken. The study is enrolling 1,600 people on four continents, including San Francisco, Boston and Chicago in the United States.

Traitement de la maladie d'Alzheimer : entre espoirs et déceptions
August 16, 2012

Les résultats contradictoires des dernières publications montrent combien la lutte contre cette redoutable maladie est difficile.

Epilepsy Drug Improves Memory in Alzheimer's Model, Patients
August 13, 2012

Researchers have found that it's possible to improve memory, even reverse memory loss, using a drug typically prescribed to treat epilepsy. Although it's still too early to recommend the drug, levetiracetam, to prevent or treat Alzheimer's disease, research results are promising.